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The existence of a cell receptor which recognises plasma high density lipoprotein (HDL) has been suggested 
from studies which demonstrate specific binding of HDL, to cultured cells derived from various tissues in 
the body. This study provides evidence of a specific HDL-binding protein in crude plasma membranes pre- 
pared from rat kidney and liver. Following separation of solubilised membrane proteins on polyacrylamide 
gel slabs and ‘Western’ blotting, one major band was identified which bound HDL,, or apo AI or apo AIL 
The protein, which was present in both liver and kidney membranes, was partially purified by repetitive 
preparative SDS-polyacrylamide gel electrophoresis and although accompanied by considerable loss of 
binding activity, could still be detected by the ligand-blotting procedure used initially to detect its presence 
in cell membranes. 
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1. INTRODUCTION 2. EXPERIMENTAL 
Several tissues are implicated in the processing 
of HDL and numerous laboratories have 
demonstrated specific binding, internalisation 
and/or degradation of HDL by cultured cells. 
Unlike LDL, which primarily donates cholesterol 
to cells, HDL is probably involved in reverse 
cholesterol transport (removal of cellular 
cholesterol) from some tissues [l], delivery of 
sterol to others (e.g. steroidogenic tissues [2-4]), 
and possibly both removal from and delivery of 
cholesterol to the liver. Thus, the processing of 
HDL is more complex and may involve different 
mechanisms for different cells. Some insight into 
these mechanisms may be gained by studies at the 
molecular level of the ligand-membrane interac- 
tion. Towards this aim, the present investigation 
has provided some clues to the existence and 
nature of the binding protein in plasma mem- 
branes obtained from both rat liver and kidney, 
two tissues known to be involved in the processing 
of plasma HDL [5]. 
Livers and kidneys were obtained from male 
Sprague-Dawley rats (180-250 g) and immediately 
placed in ice-cold phosphate-buffered saline 
(PBS). The cortex was dissected out from the 
kidneys, blotted and weighed, and homogenised 
with 5 vols buffer [20 mM Tris-HCl, 0.15 M NaCl, 
1 mM CaC12, 1 mM phenylmethylsulphonyl 
fluoride (PMSF), pH 7.51 for 2 x 15 s periods in 
a Polytron homogeniser. Rat livers were similarly 
weighed and homogenised. Homogenates of both 
were centrifuged at 3000 x g for 5 min, the super- 
natants filtered through nylon gauze and recen- 
trifuged at 3000 x g. These supernatants were cen- 
trifuged at 100000 x g for 60 min and the resulting 
membrane pellet resuspended in 0.25 M Tris- 
maleate, 1 mM PMSF (pH 6.5) and resuspended 
by aspiration through a 23-gauge needle. Protein 
concentrations were adjusted to 10 mg/ml and the 
membrane suspensions onicated for two periods 
of 15-20 s at 4°C. After adjusting the suspensions 
to 5 mg/ml protein in 0.125 M Tris-maleate, 
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0.15 M NaCl, octyl-,&D-glucopyranoside (OG) 
was added to a final concentration of 40 mM and 
the mixtures incubated at 4’C for 20 min. The 
solubilised membrane fraction was obtained by 
centrifugation at 100000 x g for 60 min and the in- 
soluble (pellet) fraction discarded. 
HDL-binding proteins were identified on mem- 
brane components which had been transferred to 
and immobilised on nitrocellulose sheets as 
described [6] for adrenal cortical membranes. 
Briefly, solubilised membrane proteins were 
separated by electrophoresis on SDS-polyacryl- 
amide gels (10%) followed by Western blotting (71. 
The nitrocellulose strips were incubated with 
150 pg/ml HDL3, or appropriate control solutions 
for 60 min at room temperature and then washed 
4 times with PBS containing 0.1% Tween 20. 
Bound HDL was detected with anti-apo AI (rab- 
bit) which in turn was identified using biotinylated 
anti-rabbit Ig and biotinylated streptavidin-HRPO 
complex (Amersham) as described in [6]. 
HDL3 (d 1.12-1.21 g/ml) was isolated from 
normolipemic human serum and washed by 
ultracentrifugation until devoid of E or B 
apolipoproteins [9]. AI and AI1 apolipoproteins 
were isolated following delipidation of HDL3 and 
monospecific antisera to these apolipoproteins 
were produced as in [lo]. Rat HDL3 was isolated 
by ultracentrifugation and antisera to rat Apo AI 
also prepared according to [lo]. 
3. RESULTS 
In a previous study, following Western blotting 
of the solubilised plasma membrane fractions of 
sheep adrenal cortical membranes, a protein band 
which recognised human HDL3 [6] was identified. 
The same band also weakly bound human LDL. 
To characterise further the ligand specificity of this 
membrane protein, strips were incubated with 
either apo AI or AII, washed and blocked and then 
incubated with their corresponding antisera. Fig. 1 
shows that as well as binding intact HDL3 (lane l), 
the same band, with a comparable electrophoretic 
mobility, also bound apo AI (lane 3) and apo AI1 
(lane 4). Lane 2 was loaded with albumin which 
did not bind HDL3. The apparent Mr of the pro- 
tein is similar (approx. 78000) to that described in 
WI. 
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Fig. 1. Binding of human HDL3 and apolipoproteins AI 
and AI1 by adrenocortical membrane receptor. Lanes 1, 
3 and 4 were loaded with solubilised membranes, lane 2 
with albumin. Following SDS-slab gel electrophoresis 
and transblotting, strips 1 and 2 were incubated with 
HDL3, strip 3 with AI and strip 4 with AI1 
apolipoprotein. Binding of proteins was detected after 
incubation with appropriate antisera as described in 
section 2. 
To investigate the distribution of this binding 
protein in tissues alleged to be involved in in vivo 
processing of HDL3 [5] solubilised plasma mem- 
brane extracts of rat kidney, and liver were similar- 
ly electrophoretically separated, transblotted, and 
incubated with lipoproteins as described above. 
Fig.2 shows that a fraction in rat kidney mem- 
branes strongly bound human HDL3 (lanes 1,2) as 
well as rat HDLs (lanes 5,6) and although more 
weakly expressed, a protein of similar M, present 
in rat liver also bound human HDL3 (lanes 3,4). 
To enable characterisation of the HDLs-binding 
protein in more detail, rat kidney and liver mem- 
brane preparations were separately subjected to 
repetitive SDS-slab gel electrophoresis, and the 
position of the HDLS-binding protein monitored 
each time by Western blotting. Fig.3 shows that 
partial purification of the protein was achieved by 
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this approach, although the binding activity 
became considerably weaker during the process. 
The position of the binding protein present in the 
solubilised membrane preparation (lane 1, 
Coomassie blue) was identified by ligand blotting 
a small section of the gel (lane 2), and the cor- 
responding band across the remainder of the gel 
was eluted and subjected to slab gel 
electrophoresis. 
This process was repeated and the final purifica- 
tion achieved is shown in fig.3, lane 3. A similar 
purification was achieved with solubilised kidney 
membranes. Lanes 4 and 5 (partially purified liver 
HDL receptor) and lanes 6-8 (partially purified 
kidney HDL receptor) show the result of ligand 
blotting, indicating that the bottom band (lane 3) 
has the binding activity. The significance of the 
two higher M, bands is unknown, although con- 
centrations of both were considerably reduced 
following incubation with mercaptoethanol prior 
to ele~trophores~s (not shown). Because reduction 
with thiol reagents appears detrimental to the 
Fig.2. Binding of human HDLs by solubilised 
membrane preparations of rat kidney (1,2) and rat liver 
(3,4) and of rat HDL by rat kidney membranes (5,6). 
Following SDS gel electrophoresis and transblotting, 
nitrocellulose strips were incubated with HDL and 
processed as described in section 2. 
Fig.3. Partial purification of binding protein by 
repetitive SDS-slab gel electrophoresis. SoiubiIised liver 
plasma membrane was electrophoresed (lane l), 
Coomassie blue stained gel, and the HDLj-binding 
protein, identified by l&and blotting (lane 2) was 
excised, and re-electrophoresed. The process was 
repeated twice, resulting in the isolation of a fraction 
characterised by one major band and two bands of 
higher h4, (Iane 3, Coomassie blue-stained). The same 
procedure was used to isolate the rat kidney HDL- 
binding protein. Retention of binding activity, although 
weakened, was apparent after loading 40 and 80pg 
purified liver protein (lanes 4.5) and 20, 40 and 8Opg 
purified kidney membrane followed by ligand blotting. 
HDL-binding capacity, ligand blotting of the par- 
tially purified binding protein(s) could not be in- 
vestigated following reduction. 
4. DISCUSSION 
An HDL-binding protein has previously been 
identified in adrenal cortical plasma membrane [6] 
and taken together with additional evidence that 
ACTH stimulates HDL binding in rat adrenals [9] 
provides strong evidence for the existence of an 
HDL receptor, at least in rat steroidogenic tissues 
which depend on HDL to deliver cholesterol as a 
precursor of steroidogenic hormones. These ex- 
periments have now shown that the same mem- 
brane protein binds both AI and AI1 apolipopro- 
teins which strengthens previous observations 
made using whole cell incubations. In these ex- 
periments, specific antibodies (Fab fragments) 
were used to inhibit binding of HDL to cultured 
cells and it was found that immunosuppression oc- 
curred in the presence of either apo AI or AI1 an- 
tibodies [IO]. 
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Additionally, we have now demonstrated that an 
HDL-binding protein is present in other tissues 
thought to be involved in the metabolism of 
plasma HDL. A protein with similar elec- 
trophoretic properties has been partially purified 
from solubilised membranes obtained from both 
rat livers and kidneys, two organs involved in the 
processing HDL, although the evidence suggests 
that apo AI, rather than the intact HDL, may be 
the major peptide recognised by the kidney [5]. 
The present ligand-blotting studies suggest that the 
concentration of the binding protein was strongest 
in kidney and weakest in liver membranes since 
more HDL was apparently bound following elec- 
trophoresis of similar concentrations of kidney 
and liver membrane (fig.2). However, the partially 
purified binding protein isolated from the kidney 
also appeared to bind more HDL than equivalent 
amounts of the liver membrane (fig.3) so it is 
possible that structural differences, affecting HDL 
binding, exist between the proteins derived from 
the two sources. One alternative explanation for 
the weaker interaction of HDLJ with liver mem- 
branes could be the choice of HDL subfraction, 
since recent evidence [l l] suggests that HDL2 may 
be the major HDL class responsible for returning 
cholesterol to the liver from peripheral tissues. 
It is of considerable interest that both the 
putative HDL receptor and the ligand appeared to 
involve protein components. Recent reports sug- 
gest that lipid moieties [ 121 or unidentified low-M,, 
non-peptide components [ 131 are responsible for 
the HDL-receptor interaction. These suggestions 
are not consistent with the present observations 
which identified the membrane-binding compo- 
nent as a stainable protein band, capable of elec- 
trophoretic transfer to nitrocellulose sheets. The 
ligands of HDL which it bound were delipidated 
apolipoproteins (AI, AH) as well as intact HDL3. 
Therefore, although these results do not exclude 
lipid (or carbohydrate) from the interaction, they 
provide strong evidence for the involvement of 
protein-protein interactions in one form of cellular 
recognition of plasma HDL3. 
Further purification is hampered by an accom- 
paniment in weakening of binding activity and by 
the possible formation of aggregates (fig.3, lane 3) 
which partially at least appear to be disulphide- 
linked. Work is proceeding to achieve a final 
purification which will enable a more detailed 
characterisation of the properties of this new 
HDL-binding protein. 
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